Free Trial

Caribou Biosciences (CRBU) Short Interest Ratio & Short Volume

Caribou Biosciences logo
$1.96 -0.03 (-1.51%)
(As of 11/20/2024 ET)

Caribou Biosciences Short Interest Data

Caribou Biosciences (CRBU) has a short interest of 9.94 million shares, representing 12.43% of the float (the number of shares available for trading by the public). This marks a -13.64% decrease in short interest from the previous month. The short interest ratio (days to cover) is 9.1, indicating that it would take 9.1 days of the average trading volume of 1.72 million shares to cover all short positions.

Current Short Interest
9,940,000 shares
Previous Short Interest
11,510,000 shares
Change Vs. Previous Month
-13.64%
Dollar Volume Sold Short
$19.48 million
Short Interest Ratio
9.1 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
90,553,000 shares
Float Size
79,990,000 shares
Short Percent of Float
12.43%
Today's Trading Volume
2,230,035 shares
Average Trading Volume
1,716,785 shares
Today's Volume Vs. Average
130%
Short Selling Caribou Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Caribou Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRBU Short Interest Over Time

CRBU Days to Cover Over Time

CRBU Percentage of Float Shorted Over Time

Caribou Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20249,940,000 shares $19.48 million -13.6%12.4%9.1 $1.96
10/15/202411,510,000 shares $22.44 million -1.4%14.4%12.8 $1.95
9/30/202411,670,000 shares $22.87 million +0.3%14.6%9 $1.96
9/15/202411,630,000 shares $24.66 million +2.2%14.6%7.9 $2.12
8/31/202411,380,000 shares $24.58 million -1.2%14.2%6.1 $2.16
8/15/202411,520,000 shares $23.96 million -7.3%14.4%5.3 $2.08
7/31/202412,430,000 shares $28.84 million +6.8%15.6%5 $2.32
7/15/202411,640,000 shares $24.79 million +13.6%14.6%4.6 $2.13
6/30/202410,250,000 shares $16.81 million -16.5%12.8%4.4 $1.64
6/15/202412,270,000 shares $21.96 million +6.6%15.4%5.3 $1.79
5/31/202411,510,000 shares $33.15 million +9.7%14.4%5.2 $2.88
5/15/202410,490,000 shares $38.18 million -1.4%13.1%5.6 $3.64
4/30/202410,640,000 shares $38.62 million -6.2%13.4%6.6 $3.63
4/15/202411,340,000 shares $46.15 million +11.2%14.2%7.1 $4.07
3/31/202410,200,000 shares $52.43 million +1.3%12.9%6.2 $5.14
3/15/202410,070,000 shares $54.08 million +7.2%12.7%6.1 $5.37
2/29/20249,390,000 shares $74.27 million -3.1%12.1%6.1 $7.91
2/15/20249,690,000 shares $67.83 million -4.3%12.5%6.2 $7.00
1/31/202410,120,000 shares $62.04 million +2.6%13.6%6.1 $6.13
1/15/20249,860,000 shares $53.64 million +2.3%13.2%5.6 $5.44
12/31/20239,640,000 shares $55.24 million -3.0%12.9%5.9 $5.73
12/15/20239,940,000 shares $60.53 million +0.5%13.7%6.5 $6.09
11/30/20239,890,000 shares $58.05 million +10.5%13.7%6 $5.87
11/15/20238,950,000 shares $41.80 million -8.5%12.4%5.3 $4.67
10/31/20239,780,000 shares $35.50 million +24.4%12.9%6 $3.63
10/15/20237,860,000 shares $32.93 million -28.9%10.4%5.3 $4.19
9/30/202311,050,000 shares $52.82 million +34.6%14.6%5.7 $4.78
9/15/20238,210,000 shares $48.11 million +20.9%10.8%2.4 $5.86
8/31/20236,790,000 shares $39.99 million -0.7%9.1%2.1 $5.89
8/15/20236,840,000 shares $45.01 million -6.2%9.2%2.2 $6.58
7/31/20237,290,000 shares $52.42 million -11.1%11.4%2.4 $7.19
7/15/20238,200,000 shares $51.66 million +31.8%12.8%2.9 $6.30
6/30/20236,220,000 shares $26.44 million -17.9%11.6%2.6 $4.25
6/15/20237,580,000 shares $34.87 million -4.3%14.2%10.1 $4.60
5/31/20237,920,000 shares $34.93 million +5.6%14.8%13.1 $4.41
5/15/20237,500,000 shares $33.75 million +9.2%14.0%13.9 $4.50
4/30/20236,870,000 shares $29.54 million +22.0%12.8%13.8 $4.30
4/15/20235,630,000 shares $25.79 million +7.9%10.5%11.1 $4.58
3/31/20235,220,000 shares $27.72 million +10.8%9.8%10.9 $5.31
3/15/20234,710,000 shares $24.30 million +10.1%8.8%9.2 $5.16
Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.
2/28/20234,280,000 shares $26.07 million -5.5%8.0%8.2 $6.09
2/15/20234,530,000 shares $30.62 million +3.7%8.5%8.4 $6.76
1/31/20234,370,000 shares $31.51 million No Change8.6%8 $7.21
1/15/20234,370,000 shares $31.55 million +14.7%8.6%7.6 $7.22
12/30/20223,810,000 shares $23.93 million +10.4%7.5%6.6 $6.28
12/15/20223,450,000 shares $26.67 million +3.3%6.8%6.1 $7.73
11/30/20223,340,000 shares $31.10 million +1.8%6.6%5.1 $9.31
11/15/20223,280,000 shares $33.13 million -9.4%6.5%4.9 $10.10
10/31/20223,620,000 shares $35.26 million -8.8%7.2%4.8 $9.74
10/15/20223,970,000 shares $37.12 million -1.5%7.8%5.2 $9.35
9/30/20224,030,000 shares $42.52 million +39.9%8.0%5.5 $10.55
9/15/20222,880,000 shares $36.84 million +15.2%5.7%3.9 $12.79
8/31/20222,500,000 shares $24.68 million -14.4%4.9%3.3 $9.87
8/15/20222,920,000 shares $29.26 million -24.4%5.8%3.8 $10.02
7/31/20223,860,000 shares $31.34 million +5.8%7.7%4.5 $8.12
7/15/20223,650,000 shares $26.13 million No Change7.3%4.4 $7.16
6/30/20223,650,000 shares $19.82 million +8.0%7.3%4.5 $5.43
6/15/20223,380,000 shares $17.91 million +0.6%6.8%4.3 $5.30
5/31/20223,360,000 shares $27.99 million +33.9%6.7%4.6 $8.33
5/15/20222,510,000 shares $22.51 million +7.7%5.1%3.7 $8.97
4/30/20222,330,000 shares $17.24 million -2.9%4.9%4.4 $7.40
4/15/20222,400,000 shares $19.54 million +1.7%5.0%4.4 $8.14
3/31/20222,360,000 shares $21.66 million +54.3%5.0%3.9 $9.18
3/15/20221,530,000 shares $13.11 million -53.4%3.2%2.5 $8.57
2/28/20223,280,000 shares $32.73 million +7.5%6.9%6.5 $9.98
2/15/20223,050,000 shares $35.35 million +1.3%6.5%6.1 $11.59
1/31/20223,010,000 shares $32.30 million +20.4%6.4%6.5 $10.73
1/15/20222,500,000 shares $29.03 million -5.3%5.3%6 $11.61
12/31/20212,640,000 shares $39.84 million +15.8%5.6%6.8 $15.09
12/15/20212,280,000 shares $38.51 million +18.1%4.8%5.5 $16.89
11/30/20211,930,000 shares $35.88 million +25.3%4.1%3.8 $18.59
11/15/20211,540,000 shares $33.46 million +32.8%3.3%2.7 $21.73
10/29/20211,160,000 shares $25.65 million -9.4%2.5%1.7 $22.11
10/15/20211,280,000 shares $26.68 million -22.4%2.7%1.7 $20.84
9/30/20211,650,000 shares $39.39 million +27.9%3.5%1.7 $23.87
9/15/20211,290,000 shares $35.54 million +29.0%2.8%1.2 $27.55
8/31/20211,000,000 shares $27.20 million +67.0%2.2%0.9 $27.20
8/13/2021598,800 shares $14.51 million No Change1.4%0.5 $24.23

CRBU Short Interest - Frequently Asked Questions

What is Caribou Biosciences' current short interest?

Short interest is the volume of Caribou Biosciences shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 9,940,000 shares of CRBU short. 12.43% of Caribou Biosciences' shares are currently sold short. Learn More on Caribou Biosciences' current short interest.

What is a good short interest ratio for Caribou Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRBU shares currently have a short interest ratio of 9.0. Learn More on Caribou Biosciences's short interest ratio.

What is a good short interest percentage for Caribou Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.43% of Caribou Biosciences' floating shares are currently sold short.

Is Caribou Biosciences' short interest increasing or decreasing?

Caribou Biosciences saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 9,940,000 shares, a decline of 13.6% from the previous total of 11,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Caribou Biosciences' float size?

Caribou Biosciences currently has issued a total of 90,553,000 shares. Some of Caribou Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Caribou Biosciences currently has a public float of 79,990,000 shares.

How does Caribou Biosciences' short interest compare to its competitors?

12.43% of Caribou Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Caribou Biosciences: SOPHiA GENETICS SA (0.05%), Vaxart, Inc. (6.35%), Cellectis S.A. (0.28%), Fate Therapeutics, Inc. (13.96%), Poseida Therapeutics, Inc. (4.50%), Atara Biotherapeutics, Inc. (16.03%), bluebird bio, Inc. (24.54%), Precision BioSciences, Inc. (5.77%), Kezar Life Sciences, Inc. (2.87%), Sangamo Therapeutics, Inc. (9.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Caribou Biosciences stock?

Short selling CRBU is an investing strategy that aims to generate trading profit from Caribou Biosciences as its price is falling. CRBU shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Caribou Biosciences?

A short squeeze for Caribou Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBU, which in turn drives the price of the stock up even further.

How often is Caribou Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBU, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:CRBU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners